Simultaneous integrated boost conformal radiotherapy in non -small cell lung cancer patients with brain metastases
Hao Wang,Lei Wu,Tianchang Wang,Tao Li,Yali Wang,Yanmei Gao,Qiufang Liu
DOI: https://doi.org/10.3969/j.issn.1672-4992.2014.09.22
2014-01-01
Journal of Modern Oncology
Abstract:Objective:To observe the local control rate,survival rate and side effects of the patients with brain me-tastases by whole brain radiotherapy (WBRT)with local simultaneous integrated boost conformal radiotherapy (SIB-CR).Methods:Seventy-six patients with brain metastasis of NSCLC were randomly divided into group A (n=42) and group B (n=34).Group A received 40Gy whole brain radiation in 20 fractions over four weeks followed by 20Gy focal radiation in 10 fractions over two weeks.Group B received 36Gy whole brain radiation in 20 fractions over four weeks with simultaneous integrated boost by 24Gy focal radiation in 20 fractions.Therapeutic effect,adverse reac-tions and survival time were evaluated.Results:Using RECIST 1 .1 treatment response evaluation criteria,the clinical symptom remission rate was 95.2%(40/42)in group A,97.1%(33/34)in group B.There was no significantly difference between group A and group B.There was no significantly difference in hematological toxicity,gastrointes-tional reaction,nervous system damage and alopecia in two groups.The median survival time,six months and 1 -year survival rates of the patients in group A were 8.94 months,71.4% and 35.7%,respectively showing no significant differences to group B were 9.47 months,82.4% and 38.2%,respectively.There was no significantly difference be-tween group A and group B in remission rate,toxic reaction and survival time.Conclusion:Whole brain irradiation with simultaneous integrated boost conformal radiotherapy technique is effective in patients with brain metastases with shorter the total radiotherapy duration and can be well tolerated.
What problem does this paper attempt to address?